While none of the proteins had already been approved drugs or drugs in clinical trials, recombinant human G-CSF (rhG-CSF), such as filgrastim and lenograstim, is used to treat the neutropenia caused by chemotherapy to stimulate the production of granulocytes from the bone marrow57. This evidence concerns the gene CSF3 and Decreased total neutrophil count.